2026 Jiake Xu: Molecular Biology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Molecular Biology	79	1040	923	24	23	351	21841
Biology and Biochemistry	83	3498	3222	81	80	420	24626

Jiake Xu publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Jiake Xu sits on this spectrum.

47 publications 564+

This scientist: 351 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Jiake Xu D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Jiake Xu sits on this spectrum.

40 D-Index 145+

This scientist: 79 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Jiake Xu is affiliated with the University of Western Australia in Australia. Their research predominantly lies within the fields of Medicine and Biochemistry, Genetics and Molecular Biology, addressing a wide spectrum of topics related to bone health, cancer mechanisms, and molecular biology.

The scientist has contributed extensively to multiple subfields including Molecular Biology, Oncology, Cancer Research, Orthopedics and Sports Medicine, and Surgery. This reflects a multidisciplinary approach emphasizing both fundamental biology and clinical implications.

The main research topics they have explored include:

Bone Metabolism and Diseases
Bone health and treatments
NF-κB Signaling Pathways
Bone and Joint Diseases
Cancer-related molecular mechanisms research
Bone health and osteoporosis research
Inflammatory mediators and NSAID effects

Jiake Xu has published in a variety of scientific journals, with frequent appearances in:

Journal of Cellular Physiology
Frontiers in Pharmacology
Frontiers in Cell and Developmental Biology
Biomedicine & Pharmacotherapy
Experimental Biology and Medicine

Their recent papers include:

"Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version)" (2020), Journal of Orthopaedic Translation
"Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma" (2021), Frontiers in Oncology
"STAT3 and its targeting inhibitors in osteosarcoma" (2020), Cell Proliferation
"Steroid-induced osteonecrosis of the femoral head reveals enhanced reactive oxygen species and hyperactive osteoclasts" (2020), International Journal of Biological Sciences
"m6A Methylation Regulates Osteoblastic Differentiation and Bone Remodeling" (2021), Frontiers in Cell and Developmental Biology

Collaboration is a significant aspect of Jiake Xu's research activities. Frequent coauthors include Jinmin Zhao, Yuangang Su, Jinbo Yuan, Qian Liu, and Kai Chen, indicating ongoing partnerships with researchers specializing in related biomedical fields.

Best Publications

Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.

Qiang Guo;Yuxiang Wang;Dan Xu;Johannes Nossent

1384
Citations
An overview of the regulation of bone remodelling at the cellular level

Jasreen Kular;Jennifer Tickner;Shek Man Chim;Jiake Xu

631
Citations
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation

Defang Li;Jin Liu;Baosheng Guo;Chao Liang

584
Citations
Porcine small intestine submucosa (SIS) is not an acellular collagenous matrix and contains porcine DNA: Possible implications in human implantation

M. H. Zheng;J. Chen;Y. Kirilak;C. Willers

508
Citations
Current research on pharmacologic and regenerative therapies for osteoarthritis.

Wei Zhang;Hongwei Ouyang;Crispin R Dass;Jiake Xu

492
Citations
Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals.

Kazuhiro Kondo;Jiake Xu;Edward S. Mocarski

381
Citations
Scaffolds for tendon and ligament repair: review of the efficacy of commercial products.

Jimin Chen;Jiake Xu;Allan Wang;Minghao Zheng

377
Citations
Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.

Lin Huang;JiaKe Xu;David J. Wood;Ming H. Zheng

353
Citations
Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction.

D. Liu;Jiake Xu;L. Figliomeni;L. Huang

346
Citations
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.

Chao Liang;Baosheng Guo;Heng Wu;Ningsheng Shao

321
Citations
The chondrocyte: biology and clinical application.

Zhen Lin;Craig Willers;Jiake Xu;Ming-Hao Zheng

318
Citations
Correction: Corrigendum: NPNT is Expressed by Osteoblasts and Mediates Angiogenesis via the Activation of Extracellular Signal-regulated Kinase

Vincent Kuek;Zhifan Yang;Shek Man Chim;Sipin Zhu

301
Citations
NF-kappaB modulators in osteolytic bone diseases.

Jiake Xu;Hua Fei Wu;Estabelle S.M. Ang;Kirk Yip

298
Citations
Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version).

Dewei Zhao;Feng Zhang;Benjie Wang;Baoyi Liu

297
Citations
Angiogenic factors in bone local environment

Shek Man Chim;Jennifer Tickner;Siu To Chow;Vincent Kuek

287
Citations
Gene Expression Profiles of Human Chondrocytes during Passaged Monolayer Cultivation

Zhen Lin;Jonathan B. Fitzgerald;Jiake Xu;Craig Willers

264
Citations
Interaction between osteoblast and osteoclast: impact in bone disease.

Tony Phan;Jiake Xu;Ming Zheng

257
Citations
Matrix-induced autologous chondrocyte implantation (MACI): biological and histological assessment.

Ming-Hao Zheng;Craig Willers;Lyn Kirilak;Piers Yates

256
Citations
Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species.

Kai Chen;Pengcheng Qiu;Yu Yuan;Yu Yuan;Lin Zheng

216
Citations
12-O-tetradecanoylphorbol-13-acetate (TPA) Inhibits Osteoclastogenesis by Suppressing RANKL-Induced NF-κB Activation

Cathy Wang;James H. Steer;David A. Joyce;Kirk H. M. Yip

193
Citations